Stock listing

Frankfurt:1T3 Syndax Pharmaceuticals, Inc. Aktie

German listing (Frankfurt) of Syndax Pharmaceuticals, Inc. · home listing NASDAQ:SNDX

Follow Syndax Pharmaceuticals, Inc. into a list and get an email when it puts out news.

Share price · FWB:1T3

€12.43 EUR +0.69 (+5.9%)

Close on Oct 30, 2026

Day range
€12.43 – €12.43 EUROct 30, 2026
Market cap
€1.11B EURAt the close on Oct 30, 2026 · price × 89.30M shares outstanding
Syndax Pharmaceuticals, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:SNDX · Home$13.10 USD-0.55 (-4.0%)3,174,069$13.62$13.75$12.91$13.65Close on Nov 2, 2026
Frankfurt:1T3€12.43 EUR+0.69 (+5.9%)—€12.43€12.43€12.43€11.74Close on Oct 30, 2026
Ticker
Frankfurt:1T3
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Frankfurt
Currency
EUR

What changed lately

Calls

Replays

  • Syndax Pharmaceuticals (NASDAQ:SNDX) Q3 2026 Earnings Call

    Mon, Nov 02, 2026 · 4:30 PM ET

    Watch Transcript
  • Syndax Pharmaceuticals (NASDAQ:SNDX) Q2 2026 Earnings Call

    Tue, Aug 04, 2026 · 4:30 PM ET

    Watch Transcript
  • Syndax Pharmaceuticals (NASDAQ:SNDX) Q1 2026 Earnings Call

    Thu, Apr 30, 2026 · 4:30 PM ET

    Watch Transcript

Latest news

All Syndax Pharmaceuticals, Inc. news

Decks

Syndax Pharmaceuticals, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
33 in the last 12 months · 202 in all · newest Nov 2, 2026 · oldest 2019
Calls
23 calls with a replay · 23 with a transcript · latest Nov 2, 2026
Decks
43 decks · latest Nov 2, 2026

Where Syndax Pharmaceuticals, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:SNDX · Home listingNASDAQUnited StatesUSD
gettex:1T3gettexGermanyEUR
Tradegate:1T3TradegateGermanyEUR
BOATS:SNDXBOATSUnited StatesUSD
LS Exchange:A2AFL6LS ExchangeGermanyEUR
Lang & Schwarz:A2AFL6Lang & SchwarzGermanyEUR
Dusseldorf:1T3DusseldorfGermanyEUR
Frankfurt:1T3 · This pageFrankfurtGermanyEUR
Munich:1T3MunichGermanyEUR
Stuttgart:1T3StuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Syndax Pharmaceuticals, Inc.